| Date:31/08/2023 | Title:Fluoroquinolone antibiotics – IMF – Reminder about restrictions of use and risk of rare side effects | Product:Medicines for human use | Type:Safety update |
| Date:31/08/2023 | Title:Product Information Updates – MIMS – Supporting the safe and effective use of medicines | Product:Medicines for human use | Type:Safety update |
| Date:27/08/2023 | Title:PRAC meeting highlights 28-31 August 2023 | Product:Medicines for human use | Type:Pharmacovigilance risk assessment committee (PRAC) |
| Date:09/08/2023 | Title:Reminder of serious health risks with Melanotan 2 self-tan products | Product:Medicines for human use | Type:Product information update (PIU) |
| Date:08/08/2023 | Title:Simponi (golimumab) – Changes to pre-filled pen injection instructions | Product:Medicines for human use | Type:Direct healthcare professional communication (DHPC) |
| Date:17/07/2023 | Title:EpiPen 300 and 150 micrograms solution for injection in pre-filled pen – Changes to hold-time instructions | Product:Medicines for human use | Type:Product information update (PIU) |
| Date:13/07/2023 | Title:Sabril 500mg film-coated tablets – PA 540/23/1 – One batch | Product:Medicines for human use | Type:Recall |
| Date:02/07/2023 | Title:PRAC meeting highlights 3-6 July 2023 | Product:Medicines for human use | Type:Pharmacovigilance risk assessment committee (PRAC) |
| Date:14/06/2023 | Title:Adakveo (crizanlizumab) – Revocation of EU marketing authorisation | Product:Medicines for human use | Type:Direct healthcare professional communication (DHPC) |
| Date:08/06/2023 | Title:Drug Safety Newsletter – Edition 112 – 9 June 2023 | Product:Medicines for human use | Type:Safety update |
